Cargando…

Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis

Systemic sclerosis (SSc) is an often fatal disease characterized by autoimmunity and inflammation, leading to widespread vasculopathy and fibrosis. Lysophosphatidic acid (LPA), a bioactive phospholipid in serum, is generated from lysophospholipids secreted from activated platelets in part by the act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tokumura, Akira, Carbone, Laura D., Yoshioka, Yasuko, Morishige, Junichi, Kikuchi, Masaki, Postlethwaite, Arnold, Watsky, Mitchell A.
Formato:	Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2009
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695151/ https://www.ncbi.nlm.nih.gov/pubmed/19521548

Ejemplares similares

Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate
por: Liu, Shian, et al.
Publicado: (2022)

An Update on Sphingosine-1-Phosphate and Lysophosphatidic Acid Receptor Transcripts in Rodent Olfactory Mucosa
por: Toebbe, JT., et al.
Publicado: (2022)

Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer’s disease
por: Forte, Nicola, et al.
Publicado: (2022)

Plasma Sphingosine-1-Phosphate Is Elevated in Obesity
por: Kowalski, Greg M., et al.
Publicado: (2013)

Mechanism of Sphingosine 1-Phosphate- and Lysophosphatidic Acid-Induced Up-Regulation of Adhesion Molecules and Eosinophil Chemoattractant in Nerve Cells
por: Costello, Richard W., et al.
Publicado: (2011)

Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models
por: Härmä, V, et al.
Publicado: (2012)

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021)

Reduced kidney levels of lysophosphatidic acids in rats after chronic administration of aristolochic acid: Its possible protective role in renal fibrosis
por: Tsutsumi, Toshihiko, et al.
Publicado: (2015)

Arachidonoyl-Phospholipid Remodeling in Proliferating Murine T Cells
por: Tomita, Michiyo, et al.
Publicado: (2004)

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
por: Masuda-Kuroki, Kana, et al.
Publicado: (2023)

Energy balance and the sphingosine-1-phosphate/ceramide axis
por: Green, Cara, et al.
Publicado: (2017)

Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension
por: Gluschke, Hans, et al.
Publicado: (2022)

Sphingosine 1-Phosphate and Atherosclerosis
por: Kurano, Makoto, et al.
Publicado: (2018)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)

Arachidonoyl-Specific Diacylglycerol Kinase ε and the Endoplasmic Reticulum
por: Nakano, Tomoyuki, et al.
Publicado: (2016)

The Balance between Sphingosine and Sphingosine-1-Phosphate Is Decisive for Mast Cell Activation after Fc∈ Receptor I Triggering
por: Prieschl, Eva E., et al.
Publicado: (1999)

Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis
por: Coldewey, Sina M., et al.
Publicado: (2016)

Pancreas lineage allocation and specification are regulated by sphingosine-1-phosphate signalling
por: Serafimidis, Ioannis, et al.
Publicado: (2017)

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)

Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease
por: Ceccom, Johnatan, et al.
Publicado: (2014)

Pathogenesis of Systemic Sclerosis
por: Pattanaik, Debendra, et al.
Publicado: (2015)

Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis
por: Chiba, Kenji, et al.
Publicado: (2012)

Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
por: Pérez-Jeldres, Tamara, et al.
Publicado: (2021)

An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis
por: Dumitrescu, Laura, et al.
Publicado: (2023)

Effect of N-arachidonoyl-l-serine on human cerebromicrovascular endothelium()
por: Kino, Tomoyuki, et al.
Publicado: (2016)

Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate
por: Mishima, Yuko, et al.
Publicado: (2018)

Irisin Is Target of Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor-Mediated Signaling in Skeletal Muscle Cells
por: Pierucci, Federica, et al.
Publicado: (2023)

Sphingosine Kinases/Sphingosine-1-Phosphate and Death Signalling in APP-Transfected Cells
por: Gassowska, Magdalena, et al.
Publicado: (2014)

Characterizing Sphingosine Kinases and Sphingosine 1-Phosphate Receptors in the Mammalian Eye and Retina
por: Porter, Hunter, et al.
Publicado: (2018)

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
por: Cannavo, Alessandro, et al.
Publicado: (2017)

Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis
por: Musella, Alessandra, et al.
Publicado: (2020)

Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article
por: Cohan, Stanley, et al.
Publicado: (2020)

Correction to: Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
por: Pérez-Jeldres, Tamara, et al.
Publicado: (2021)

Convergent Regulation of Neuronal Differentiation and Erk and Akt Kinases in Human Neural Progenitor Cells by Lysophosphatidic Acid, Sphingosine 1-Phosphate, and LIF: Specific Roles for the LPA1 Receptor
por: Callihan, Phillip, et al.
Publicado: (2014)

Sphingosine kinase 1 is involved in triglyceride breakdown by maintaining lysosomal integrity in brown adipocytes
por: Morishige, Jun-ichi, et al.
Publicado: (2023)

Sphingosine‐1‐phosphate improves outcome of no‐reflow acute myocardial infarction via sphingosine‐1‐phosphate receptor 1
por: Polzin, Amin, et al.
Publicado: (2022)

Sphingosine-1-Phosphate-Specific G Protein-Coupled Receptors as Novel Therapeutic Targets for Atherosclerosis
por: Okamoto, Yasuo, et al.
Publicado: (2011)

Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis
por: Schmitz, K., et al.
Publicado: (2017)

Commentary: The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension
por: Bhavanam, Naga P., et al.
Publicado: (2015)

Flotillin proteins recruit sphingosine to membranes and maintain cellular sphingosine-1-phosphate levels
por: Riento, Kirsi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_345g3tavc7he762oas6gp5nvgt